BPC-157 for Tissue Repair and Recovery — Performance & Recovery
Body Protection Compound for accelerating healing of tendons, ligaments, and muscle tissue.
Overview
BPC-157 is a synthetic 15-amino-acid peptide derived from a protective protein in gastric juice. Extensive preclinical evidence (35+ animal studies) demonstrates accelerated healing of tendons, ligaments, muscle, and gut tissue through angiogenesis (VEGF/VEGFR2), growth hormone receptor activation, collagen synthesis, and anti-inflammatory pathways. Human evidence is limited: 2024 systematic review found only one small clinical study (n=12 knee pain); 2025 safety pilot (n=2) showed no adverse effects; historical IBD Phase II trials mentioned but not fully published. Mechanisms include FAK-paxillin pathway activation for cell migration and nitric oxide modulation. PMID: 21030672, 40131143, 18818478
Indications
- Tendon and ligament injuries (tennis elbow, achilles tendinopathy)
- Muscle strains and tears
- Joint injuries and inflammation
- Post-surgical recovery enhancement
- Gut healing and inflammatory bowel disease
Mechanism of Action
Tendon, ligament, or muscle injury creates inflammation, damaged tissue, and impaired healing cascade
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| BPC-157 | 250-500 mcg | Once or twice daily | Local administration near injury site preferred |
| BPC-157 | 500-1000 mcg | Once or twice daily | For gut healing applications |
Evidence Grade
GRADE C
Safety & Contraindications
- IMPORTANT: Human safety data is extremely limited (only n=2 pilot study published)
- Extensive preclinical data shows good tolerability in animal models
- Not FDA-approved; no large-scale human trials completed
- Theoretical cancer risk due to angiogenic effects - untested in humans long-term
- Use sterile technique for all injections
- Consider experimental nature when using clinically